The Sun -Taro acquisition saga continues
Indian CRAMS player Suven Life Sciences Ltd has been granted two new US patents for its class of selective 5-HT compounds for the treatment of disorders associated with neurodegenerative diseases like Alzheimer's disease, Parkinson and schizophrenia .
Glenmark plans to produce cancer drugs from its injectable unit in Argentina
Dr Reddy's is the first to launch nateglinide generic, but likely to share exclusivity with Teva, Par.
Artus Influenza/H1 RG/LC RT-PCR Kit supports Tamiflu (oseltamivir)-resistance screening, says Qiagen